SCHEMBL2848285

SCHEMBL2848285

COC(=O)Cc1ccc(C(O)c2ccc(F)cc2)c(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 5/20 0.49
PSEN1 P49768 2/20 0.46
PSEN2 P49810 2/20 0.46
APH1B Q8WW43 2/20 0.46
NCSTN Q92542 2/20 0.46
APH1A Q96BI3 2/20 0.46
PSENEN Q9NZ42 2/20 0.46
KCNH2 Q12809 2/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
PDK2 Q15119 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
LMNA P02545 1/20 0.37
APP P05067 1/20 0.37
PPARA Q07869 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2844382 0.91 CASR (0.50) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL7806884 0.88 CASR (0.49) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL2847936 0.83 KCNH2 (0.55) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL7811140 0.81 PSEN1 (0.50) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL2846362 0.80 PSEN1 (0.46) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL7807546 0.80 PSEN1 (0.48) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL2846688 0.80 PSEN1 (0.56) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL4597184 0.79 PSEN1 (0.70) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL4624986 0.79 PSEN1 (0.60) CASRPSEN1PSEN2APH1BNCSTN
SCHEMBL2843963 0.79 CYP2C8 (0.50) CASRPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138901-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS, DERIVATIVES THEREOF, AND RELATED METHODS OF USE BIOGEN IDEC MA INC (US) 2010-12-02 WO disclosed